Seres Therapeutics Financial Overview
Seres Therapeutics's market cap is currently $138.41M. The company's EPS TTM is $0.94; its P/E ratio is 25.20; Seres Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-2.11. See an overview of income statement, balance sheet, and cash flow financials.
